LeonaBio (LONA) Net Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -175.29% |
| Dec 31, 2025 | 4,808.92% |
| Sep 30, 2025 | 115.04% |
| Jun 30, 2025 | 70.21% |
| Mar 31, 2025 | 23.53% |
| Dec 31, 2024 | -479.06% |
| Sep 30, 2024 | -217.49% |
| Jun 30, 2024 | 133.16% |
| Mar 31, 2024 | 35.38% |
| Dec 31, 2023 | -499.57% |
| Sep 30, 2023 | -139.00% |
| Jun 30, 2023 | -10.41% |
| Mar 31, 2023 | 3.29% |
| Dec 31, 2022 | 213.97% |
| Sep 30, 2022 | 64.81% |
| Jun 30, 2022 | -404.04% |
| Mar 31, 2022 | 133.22% |
| Dec 31, 2021 | 113.17% |
| Sep 30, 2021 | -728.49% |
| Jun 30, 2021 | -94.23% |
| Mar 31, 2021 | 163.94% |
| Dec 31, 2020 | -230.46% |
| Sep 30, 2020 | -2.29% |
| Jun 30, 2020 | 12,278.98% |
| Mar 31, 2020 | 397.32% |